English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Multimedia Press Releases
BayWa r.e. Reaffirms Continued Commitment to the Community of Lang Son Province with Improved Sanitation Facilities for Elementary Schools
BayWa r.e. Reaffirms Continued Commitment to the Community of Lang Son Province with Improved Sanitation Facilities for Elementary Schools
March 4 2022, 09:00 HKT
more details
BayWa r.e. Reaffirms Continued Commitment to the Community of Lang Son Province with Improved Sanitation Facilities for Elementary Schools
BayWa r.e. Reaffirms Continued Commitment to the Community of Lang Son Province with Improved Sanitation Facilities for Elementary Schools
March 4 2022, 09:00 HKT
more details
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
March 3 2022, 12:10 HKT
more details
Fujitsu Leverages World's Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City
Fujitsu Leverages World's Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City
March 3 2022, 09:16 HKT
more details
Fujitsu Leverages World's Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City
Fujitsu Leverages World's Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City
March 3 2022, 09:16 HKT
more details
Oculis 获Accure Therapeutics授权引进用于治疗青光眼的神经保护候选药物 进一步强化集团的领先眼科产品线
Oculis 获Accure Therapeutics授权引进用于治疗青光眼的神经保护候选药物 进一步强化集团的领先眼科产品线
March 2 2022, 20:49 HKT
more details
Oculis獲Accure Therapeutics授權引進用於治療青光眼的神經保護候選藥物 進一步強化集團的領先眼科產品線
Oculis獲Accure Therapeutics授權引進用於治療青光眼的神經保護候選藥物 進一步強化集團的領先眼科產品線
March 2 2022, 20:48 HKT
more details
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
March 2 2022, 20:47 HKT
more details
创科实业二零二一年创下非凡业绩 收入及盈利录得骄人增长
创科实业二零二一年创下非凡业绩 收入及盈利录得骄人增长
March 2 2022, 18:12 HKT
more details
創科實業二零二一年創下非凡業績 收入及盈利錄得驕人增長
創科實業二零二一年創下非凡業績 收入及盈利錄得驕人增長
March 2 2022, 18:11 HKT
more details
Techtronic Industries Delivers Exceptional 2021 Results with Outstanding Revenue and Profit Growth
Techtronic Industries Delivers Exceptional 2021 Results with Outstanding Revenue and Profit Growth
March 2 2022, 18:10 HKT
more details
Fujitsu Honored by the International Headache Society
Fujitsu Honored by the International Headache Society
March 2 2022, 17:06 HKT
more details
Fujitsu Honored by the International Headache Society
Fujitsu Honored by the International Headache Society
March 2 2022, 17:06 HKT
more details
Fujitsu Honored by the International Headache Society
Fujitsu Honored by the International Headache Society
March 2 2022, 17:06 HKT
more details
中信国际电讯CPC全力支持香港抗疫 为企业免费提供「云.网.安」抗疫三保 保障企业业务安全运作
中信国际电讯CPC全力支持香港抗疫 为企业免费提供「云.网.安」抗疫三保 保障企业业务安全运作
March 2 2022, 15:19 HKT
more details
中信國際電訊CPC全力支援香港抗疫 為企業免費提供「雲‧網‧安」抗疫三保 保障企業業務安全運作
中信國際電訊CPC全力支援香港抗疫 為企業免費提供「雲‧網‧安」抗疫三保 保障企業業務安全運作
March 2 2022, 15:18 HKT
more details
CITIC Telecom CPC Supports the Fight Against the Epidemic, Free "Cloud, Network, Security" Anti-epidemic Trio Pack Ensures Business Continuity
CITIC Telecom CPC Supports the Fight Against the Epidemic, Free
March 2 2022, 15:17 HKT
more details
Avance Clinical悉尼辦公室正式啟動
Avance Clinical悉尼辦公室正式啟動
March 2 2022, 15:00 HKT
more details
嬴彻科技完成1.88亿美元融资,君联资本联合领投
嬴彻科技完成1.88亿美元融资,君联资本联合领投
March 2 2022, 14:24 HKT
more details
嬴徹科技完成1.88億美元融資,君聯資本聯合領投
嬴徹科技完成1.88億美元融資,君聯資本聯合領投
March 2 2022, 14:23 HKT
more details
Avance Clinical悉尼办公室正式启动
Avance Clinical悉尼办公室正式启动
March 2 2022, 15:00 HKT
more details
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
March 2 2022, 14:22 HKT
more details
Avance Clinical Announces New Office Opening in Sydney
Avance Clinical Announces New Office Opening in Sydney
March 2 2022, 15:00 HKT
more details
MHI Joins "ACT FOR SKY," a voluntary organization working for the Commercialization, Promotion and Expansion of Domestically Produced SAF
MHI Joins
March 2 2022, 12:16 HKT
more details
NEC Releases New iPASOLINK VR4 and 25Gbps Capable iPASOLINK EX Advanced Dual to Support Increased Capacity for 5G Networks
NEC Releases New iPASOLINK VR4 and 25Gbps Capable iPASOLINK EX Advanced Dual to Support Increased Capacity for 5G Networks
March 2 2022, 09:55 HKT
more details
NTT DOCOMO and NEC are Onboarding 5G SA Core Using Energy-efficient and High-performance AWS Cloud Computing Services
NTT DOCOMO and NEC are Onboarding 5G SA Core Using Energy-efficient and High-performance AWS Cloud Computing Services
March 1 2022, 14:47 HKT
more details
JCB launches the IRCTC BoB RuPay JCB Credit Card
JCB launches the IRCTC BoB RuPay JCB Credit Card
March 3 2022, 09:00 HKT
more details
Winklevoss twins and global decacorn invest in US$29M Series A of Singapore-based fintech Volopay as it prepares APAC and MENA expansion
Winklevoss twins and global decacorn invest in US$29M Series A of Singapore-based fintech Volopay as it prepares APAC and MENA expansion
March 1 2022, 18:00 HKT
more details
MHIENG Receives Highest Award among 2021 Outstanding Energy-Efficient and Decarbonizing Industrial Machinery & Systems
MHIENG Receives Highest Award among 2021 Outstanding Energy-Efficient and Decarbonizing Industrial Machinery & Systems
March 1 2022, 13:55 HKT
more details
MHIENG Receives Highest Award among 2021 Outstanding Energy-Efficient and Decarbonizing Industrial Machinery & Systems
MHIENG Receives Highest Award among 2021 Outstanding Energy-Efficient and Decarbonizing Industrial Machinery & Systems
March 1 2022, 13:55 HKT
more details
 ACN Search:
 
Spritzer EcoParks colourful Chinese New Year decorations light up the auspicious season, bringing festive cheer to all visitors
 
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575